(Q33328096)

25 July 2017

title

Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine (English)

1 reference

25 July 2017

C D Flombaum

1

1 reference

25 July 2017

J A Mouradian

2

1 reference

25 July 2017

E S Casper

3

1 reference

25 July 2017

R A Erlandson

4

1 reference

25 July 2017

F Benedetti

5

1 reference

25 July 2017

publication date

1 March 1999

1 reference

American Journal of Kidney Diseases

25 July 2017

published in

1 reference

25 July 2017

volume

33

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

555-562

1 reference

Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine).

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Clinical, toxicological and pharmacological aspects of gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Gemcitabine-induced hemolytic uremic syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Microangiopathic hemolytic anemia in metastatic carcinoma. Report of eight cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

Renal complications of mitomycin C therapy with special reference to the total dose

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970194-0

7 January 2021

10.1016/S0272-6386(99)70194-0

Identifiers

DOI

1 reference

25 July 2017

1 reference